Procter & Gamble Hygiene Q2 FY26 Results

Revenue up 2.3% to ₹1,160 Cr, maintains exceptional ROCE of 104%

₹ 13,162
-1.78% decreased today
06 Nov - close price

Financial Performance Overview

Mumbai, India, November 6, 2025: Procter & Gamble Hygiene and Health Care Limited announced its unaudited financial results for the quarter ended 30th September 2025, delivering steady revenue growth and maintaining exceptional profitability metrics including ROCE of 104% and debt-free balance sheet.

📊 Key Financial Highlights (Q2 FY26)

Revenue
₹1,160.97 Cr
+2.3% YoY
Profit Before Tax
₹281.78 Cr
Steady
PAT
₹209.84 Cr
Strong
Basic EPS
₹64.65
Per Share

📈 Quarterly Performance Comparison

Financial Metric Q2 FY26 Q2 FY25 YoY Change Performance
Revenue (₹ Cr) 1,160.97 1,135.16 +2.3% Steady
Profit Before Tax (₹ Cr) 281.78 285.37 -1.3% Stable
PAT (₹ Cr) 209.84 211.90 -1.0% Strong
Basic EPS (₹) 64.65 65.28 -1.0% Healthy

Six Months Performance (H1 FY26)

📅 Half Yearly Financial Summary

H1 Revenue
₹2,102.79 Cr
+1.1% YoY
H1 PAT
₹401.92 Cr
+72.8% YoY
H1 EPS
₹123.82
+37.2% YoY

Note: The significant improvement in H1 PAT and EPS is primarily due to the change in financial year from June 30th to March 31st, making YoY comparisons more meaningful on quarterly basis.

Business Segment Performance

🏥 Operating Segments

  • Health Care Products: Comprising of Ointments and Creams, Cough Drops and Tablets
  • Hygiene Products: Comprising of Feminine Hygiene Products and other skin care hygiene
  • Single Reportable Segment: Manufacturing, trading and marketing of Health and Hygiene Products
  • 📊 Revenue Breakdown

  • Sale of Products: ₹1,148.95 Cr (Q2 FY26)
  • Other Operating Revenues: ₹12.02 Cr (Q2 FY26)
  • Other Income: ₹9.90 Cr (Q2 FY26)
  • Balance Sheet Strength

    💼 Financial Position as of September 30, 2025

    Total Assets
    ₹313.24 Cr
    Total Equity
    ₹93.13 Cr
    Cash & Equivalents
    ₹79.21 Cr
    Total Debt
    ₹0.00 Cr
    Debt-Free

    Stock Performance & Key Metrics

    💹 Procter & Gamble Hygiene Stock Analysis

    Market Cap
    ₹42,696 Cr
    Current Price
    ₹13,162
    52W High / Low
    ₹16,250 / 12,106
    Stock P/E
    51.6
    Book Value
    ₹287
    Dividend Yield
    0.84%
    ROCE
    104%
    ROE
    75.7%
    Face Value
    ₹10.0
    EPS
    ₹255
    Debt to Equity
    0.00

    About Procter & Gamble Hygiene and Health Care Limited

    🏢 Company Overview

    Procter & Gamble Hygiene and Health Care Limited is one of India's leading players in the fast-moving consumer goods (FMCG) sector, with a strong portfolio of health and hygiene products including feminine care, healthcare, and skin care products.

    🎯 Business Highlights

  • Core Business: Health Care and Hygiene Products including feminine care, ointments, creams, and tablets
  • Market Leadership: Strong brand presence with trusted products in Indian households
  • Parent Company: Part of global Procter & Gamble Company
  • Financial Year: Changed from June 30th to March 31st effective 2024-25
  • Manufacturing: Strong manufacturing and distribution capabilities across India
  • Brand Portfolio: Includes well-known brands in feminine hygiene and healthcare segments
  • Overall Performance Assessment: Procter & Gamble Hygiene delivered a steady Q2 FY26 performance with 2.3% revenue growth and maintained strong profitability with PAT of ₹209.84 Cr. The company continues to demonstrate exceptional financial metrics with ROCE of 104% and ROE of 75.7%, supported by a debt-free balance sheet. The stock trades at a premium P/E of 51.6, reflecting the market's confidence in the company's strong brand positioning, consistent performance, and superior return ratios in the FMCG sector.

    Other Financial Articles

    Disclaimer

    This article is for educational purposes only and does not constitute investment advice. The financial data and analysis mentioned are based on company filings and market observations. Always verify current information from official sources before investing. Stock market investments carry risks including liquidity risk, volatility, and capital loss risk. Always do your own research and consider consulting with a qualified financial advisor before making investment decisions. Past performance is not indicative of future results.